Program

  Wednesday, October 14, 2020

  Thursday, October 15, 2020

  Friday, October 16, 2020

  Saturday, October 17, 2020



  Wednesday, October 14, 2020

[« back]
• Online Room
Time Activity
6:15pm-6:30pmOpening Ceremony
6:30pm-8pmSession: Advances in neuroimaging
Conectivity, cognition and fatigue in MS: How are they related?
Clinical use of PET-MRI in demyelinating diseases
Myelin imaging: New frontiers of quantitative imaging
Discussion
8pm-9pmPharma symposium
9pm-10pmAluízio Marques Lecture
MS and NMOSD in COVID-19 Era

  Thursday, October 15, 2020

[« back]
• Online Room
Time Activity
08am-10amScientific session: CTRIMS Session
Silent progression in RRMS: clinical and cognitive aspects
Genetics of multiple sclerosis: A review
Preditors of outcome in pediatric NMOSD
Discussion
10am-11amPharma symposium
11am-0:30pmScientific session: Translational symposium in Demyelinating Diseases
Multiple Sclerosis: does translational neuroimmunology exist?
B cell directed immunotherapy of multiple sclerosis: From bench to bedside
In vivo imaging system as a robust and promising tool for neuroimmunology
Discussion
6:30pm-8pmScientific session: Top 10 of the year: how the best papers impact our practice
Panel
8pm-9pmPharma symposium
9pm-10:30pmScientific session: LACTRIMS

  Friday, October 16, 2020

[« back]
• Online Room
Time Activity
08am-09:30amScientific session: Epidemiology of Neuromyelitis Optica Spectrum Disorders
The World epidemiology of NMOSD
NMOSD in Brazil
Causes and risk of death in NMOSD
Discussion
09:30am-10:30amPharma symposium
10:30am-12pmScientific session: Neuromyelitis optica spectrum disorders – Part I
Pathology and pathophysiology of NMOSD
Visual involvement in NMOSD
Immunopathophysiology of MOG-related disorders
Discussion
6:30pm-8pmScientific session: Neuromyelitis optica spectrum session disorders - Part II
Differential diagnosis of transverse myelitis
Biomarkers in diagnosis of demyelinating diseases of the CNS
Monoclonal Ab in the treatment of NMOSD: Why? When? Which?
Discussion
8pm-9pmPharma symposium
9pm-10:30pmScientific session: LACTRIMS

  Saturday, October 17, 2020

[« back]
• Online Room
Time Activity
08am-10amEuropean Charcot Foundation Symposium: PRO Value and Limitations
Methodological aspects: Value and limitations
PRO: The patient's perspective
PROMS Initiative
Role of PRO in treatment assessment
Discussion
10am-11amPharma symposium
11am-0:45pmHarvard medical school symposium
The role of complement treatments in NMOSD, MOG and MS
To be defined
Best treatment strategies for MOG disease: Acute attacks and immunosuppression
Updates in PML and MS
Misdiagnosis of MS: Common clinical pitfalls
Diagnosis and treatment of patients with spinal cord MS phenotype
Can MS and MOG disease co-exist?
0:45pm-1pmClosing Remarks: Closing remarks and invitation to BCTRIMS 22nd Annual Meeting, 2021





Management


Travel Agency


Support by


Patrocinador Ouro


Patrocinador Prata